Duloxetine (Cymbalta): A Potential Off-Label Treatment for Migraine

Duloxetine (Cymbalta): A Potential Off-Label Treatment for Migraine

Cerebral Torque

Click for the full list of the 50 uncommon migraine preventives

What is Duloxetine?

Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI). Therefore, it inhibits the reuptake of serotonin and norepinephrine.

SNRIs mechanism of action | Download Scientific Diagram

As you can see in this picture, blocking the reuptake (termed reabsorption in the picture) of serotonin and norepinephrine will increase their concentration in the synapses and, therefore, the brain. 

Duloxetine is a prescription medication that is FDA-approved for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), diabetic peripheral neuropathic pain (DPNP), fibromyalgia (FM), and chronic musculoskeletal pain. It is also sometimes used off-label for migraine prevention. Many of the aforementioned conditions are also comorbid conditions of migraine and hence why this medication may be more appealing for those patients. 

How Does Duloxetine Work?

As we stated earlier, duloxetine works by inhibiting the reuptake of serotonin and norepinephrine thereby increasing their levels in the brain. It is important to note that SNRIs are more effective than SSRIs for migraine prevention although they are both used off-label. 

Duloxetine as a Potential Treatment Option for Migraine

There are no randomized controlled trials for duloxetine, but smaller studies are available. 

In one study, there was efficacy of duloxetine in patients with coexisting depression and medication overuse due to chronic migraine. 

Source

In another study, it was found that migraine prophylactic treatment with high-dose duloxetine may be effective in a nondepressed individual.  

Source

Potential Side Effects of Duloxetine

Common side effects of duloxetine include nausea, headache, dry mouth, insomnia, and constipation. If you experience any severe side effects or have concerns about taking this medication, it is important to speak with your healthcare provider.

There is an FDA black box warning against duloxetine as it carries an ncreased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders. Duloxetine is not approved for use in pediatric patients

Other Considerations for Duloxetine

Duloxetine is generally prescribed to those patients that cannot be prescribed venlafaxine. 

It is important to talk to your neurologist when planning on stopping this medication. 

Do not use duloxetine if you have used an MAO inhibitor in the past 14 days.

Risk of serotonin syndrome if used with triptans, but unlikely. Speak to your healthcare provider.

This is a cursory understanding of uncommon migraine medications. This is only to be used as a resource to go to your neurologist with. 

Back to blog
  • A Breakthrough on the Horizon: PACAP-Targeting Antibodies Offer New Promise for Migraine Prevention

    A Breakthrough on the Horizon: PACAP-Targeting ...

    Cerebral Torque

    Migraine patients may soon have a new treatment option. Recent clinical trials show promising results for Lu AG09222, a monoclonal antibody targeting PACAP, a neuropeptide involved in migraine pathophysiology.

    A Breakthrough on the Horizon: PACAP-Targeting ...

    Cerebral Torque

    Migraine patients may soon have a new treatment option. Recent clinical trials show promising results for Lu AG09222, a monoclonal antibody targeting PACAP, a neuropeptide involved in migraine pathophysiology.

  • New Study Maps Migraine Symptoms Across Attack Phases

    New Study Maps Migraine Symptoms Across Attack ...

    Cerebral Torque

    Symptom Pre-headache* Headache* Post-headache* Interictal* Pooled %** Notes Head pain 50% 100% 28% 5% 100% Only universally reported symptom; defining feature of headache phase Light sensitivity 75% 80% 30% 13%...

    New Study Maps Migraine Symptoms Across Attack ...

    Cerebral Torque

    Symptom Pre-headache* Headache* Post-headache* Interictal* Pooled %** Notes Head pain 50% 100% 28% 5% 100% Only universally reported symptom; defining feature of headache phase Light sensitivity 75% 80% 30% 13%...

  • White Matter Lesions in Migraine Patients: What You Need to Know

    White Matter Lesions in Migraine Patients: What...

    Cerebral Torque

    Discover what white matter lesions mean for migraine patients. This guide explores the latest research on the relationship between migraine and brain changes, offering insights into prevalence, potential causes, and...

    White Matter Lesions in Migraine Patients: What...

    Cerebral Torque

    Discover what white matter lesions mean for migraine patients. This guide explores the latest research on the relationship between migraine and brain changes, offering insights into prevalence, potential causes, and...

  • Gepant Adverse Events Chart

    Gepant Adverse Events Chart

    Cerebral Torque

    A comprehensive analysis of real-world data has uncovered important insights into the safety profiles of gepant medications used for migraine treatment. The study, which examined adverse events reported in the...

    Gepant Adverse Events Chart

    Cerebral Torque

    A comprehensive analysis of real-world data has uncovered important insights into the safety profiles of gepant medications used for migraine treatment. The study, which examined adverse events reported in the...

1 of 4